Rationale of platelet gel to augment adaptive remodeling of the injured heart

Journal of Extra-Corporeal Technology

Volumn 36, Issue 2, 2004, Pages 191-196

  Mogan, Christopher ^a   Larson, Douglas F ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Fibroblasts; Growth factors; Remodeling

Indexed keywords

CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GROWTH HORMONE; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ADAPTATION; AGING; ANGIOGENESIS; ARTICLE; CELL REGENERATION; EXTRACELLULAR MATRIX; GEL; HEART DISEASE; HEART HYPERTROPHY; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; PLATELET GEL; THROMBOCYTE ACTIVATION; VIRUS INFECTION; VIRUS MYOCARDITIS; WOUND HEALING;

EID: 3142742302     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofacial Surg. 1997;55:1294-9.
2. Wajon P, Gibson J, Calcroft R, et al. Intraoperative plateletpheresis and autologous platelet gel do not reduce chest tube drainage or allogeneic blood transfusion after reoperative coronary artery bypass graft. Anesth Analges. 2001;93:536-42.
3. Gillingham B, Polston G, Hannon T, et al. Multicomponent pheresis and autologous platelet gel in adolescent spinal surgery. Pediatrics. 1999;104:708-9.
4. Robiony M, Polini F, Costa F, et al. Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: Preliminary results. J Oral Maxillofacial Surg. 2002;60:630-5.
5. Delcayre C, Swynghedauw B. Molecular mechanisms of myocardial remodeling. The role of aldosterone. J Molec Cellu Cardiol. 2002;34:1577-84.
6. Kellar RS, Lundeen TK, Shepard BR, Naughton GK, Ratchlife A, Williams SK. Scaffold-based three dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infracted heart tissue. Circulation. 2001;104:2063-8.
7. Canalis E, McCarthy TL, Centrella M. Effects of platelet-derived growth-factor on bone-formation in vitro. J Cellu Physiol. 1989;140:530-7.
8. Shackelford DP, Fackler E, Hoffman MK, et al. Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation. Am J Obst Gynecol. 2002;186:701-4.
9. Zimmermann R, Jakubietz R, Jakubietz M, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion. 2001;41:1217-24.
10. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofacial Surg. 2000;58:297-300.
11. Gilsanz F, Escalante F, Auray C, et al. Treatment of leg ulcers in beta-thalassaemia intermedia: Use of platelet-derived wound healing factors from the patient's own platelets. Brit J Haematol. 2001;115:710.
12. Soslau G, Morgan DA, Jaffe JS, et al. Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function. Cytokine. 1997;9:405-11.
13. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiolog Revs. 1999;79:1283-316.
14. Betsholtz C, Karlsson L, Lindahl P. Developmental roles of platelet-derived growth factors. Bioessays. 2001;23:494-507.
15. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344:1750-7.
16. Baxter RC. Changes in the IGF-IGFBP axis in critical illness. Best Pract Res Clin Endocrinol Metab. 2001;15:421-34.
17. Donath MY, Sutsch G, Yan XW, et al. Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinol Metab. 1998;83:3177-83.
18. Cordeiro MF. Beyond mitomycin: TGF-beta and wound healing. Prog Retinal Eye Res. 2002;21:75-89.
19. Song QH, Klepeis VE, Nugent MA, et al. TGF-beta 1 regulates TGF-beta 1 and FGF-2 mRNA expression during fibroblast wound healing. J Clin Pathol-Molec Pathol. 2002;55:164-76.
20. Sun Y, Zhang JQ, Zhang J, et al. Angiotensin II, transforming growth factor-beta1 and repair in the infarcted heart. J Mol Cell Cardiol. 1998;30:1559-69.
21. Derhaschnig U, Shehata M, Herkner H, et al. Increased levels of transforming growth factor-beta 1 in essential hypertension. Am J Hypertens. 2002;15:207-11.
22. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone-Biology and clinical applications. J Bone Joint Surg - American Volume. 2002;84A:1032-44.
23. Radomsky ML, Thompson AY, Spiro RC, et al. Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthopaed Related Res. 1998;355:S283-93.
24. Zhang CX, Yang J, Feng JZ, et al. Short-term administration of basic fibroblast growth factor enhances coronary collateral development without exacerbating atherosclerosis and balloon injury-induced vasoproliferation in atherosclerotic rabbits with acute myocardial infarction. J Lab Clin Med. 2002;140:119-25.
25. Rumalla VK, Borah GL. Cytokines, growth factors, and plastic surgery. Plastic Reconstruct Surg. 2001;108:719-33.
26. Sawhney RS, Zhou GHK, Humphrey LE, et al. Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands. J Biolog Chem. 2002;277:75-86.
27. Beltrami CA, Finato N, Rocco M, et al. The cellular basis of dilated cardiomyopathy in humans. J Molec Cellu Cardiol. 1995;27:291-305.
28. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344:1750-7.
29. Azizi SA, Stokes D, Augelli BJ, et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-Similarities to astrocyte grafts. Proc Natl Acad Sci USA. 1998;95:3908-13.
30. Mezey E, Chandross KJ, Harta G, et al. Turning blood into brain: Cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000;290:1779-82.
31. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science. 1998;279:1528-30.
32. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390-4.
33. Petersen BE, Bowen WC, Patrene KD, et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999;284:1168-70.
34. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999;100:II247-56.
35. Kessler PD, Byrne BJ. Myoblast cell grafting into heart muscle: Cellular biology and potential applications. Ann Rev Physiol. 1999;61:219-42.
36. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-5.
37. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395-402.
38. Bittner RE, Schofer C, Weipoltshammer K, et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl). 1999;199:391-6.
39. Powell DW, Mifflin RC, Valentich JD, et al. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol. 1999;277: C1-9.
40. Hawrylowicz CM, Santoro SA, Platt FM, et al. Activated platelets express II-1 activity. J Immunol. 1989;143:4015-8.
41. Krakauer T, Vilcek J, Oppenheim J. Proinflammatory Cytokines. In: Fundamental Immunology. Paul W, ed. New York: Lippincott-Raven; 1999:775-811.
42. Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion. 1994;34:20-5.
43. Stacker SA, Runting AS, Caesar C, et al. The 3T3-L1 fibroblast to adipocyte conversion is accompanied by increased expression of angiopoietin-1, a ligand for Tie2. Growth Factors. 2000;18:177-91.
44. Browder T, Folkman J, Pirie-Shepherd S. The hemostatic system as a regulator of angiogenesis. J Biolog Chem. 2000;275:1521-4.
45. Trompezinski S, Denis A, Vinche A, et al. IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts. Experiment Dermatol. 2002;11:224-31.
46. Boehlen F, Clemetson KJ. Platelet chemokines and their receptors: What is their relevance to platelet storage and transfusion practice? Transfus Med. 2001;11:403-17.
47. Vaddi K, Keller M, Newton R. The Chemokine Facts Book. 1st ed. New York: Academic Press; 1997.
48. Menten P, Proost P, Struyf S, et al. Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity. Euro J Immunol. 1999;29:678-85.
49. Wise H, Wong YH, Jones RL. Prostanoid signal integration and cross talk. Neurosignals. 2002;11:20-8
50. Petrov V, Fagard RH, Lijnen P. Stimulation of angiotensin converting enzyme by transforming growth factor-beta (1) in rat cardiac fibroblasts. J Hypertens. 2000;18;S123-4.